Psutka SP, Leibovich BC. Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma. Ther Adv Urol. 2015;7(4):216–29.
Article
PubMed
PubMed Central
Google Scholar
Skinner DG, Pritchett TR, Lieskovsky G, Boyd SD, Stiles QR. Vena caval involvement by renal cell carcinoma. Surgical resection provides meaningful long-term survival. Ann Surg. 1989;210(3):387–92 discussion 92–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, et al. Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol. 2003;169(3):909–16.
Article
PubMed
Google Scholar
Agochukwu N, Shuch B. Clinical management of renal cell carcinoma with venous tumor thrombus. World J Urol. 2014;32(3):581–9.
Article
PubMed
Google Scholar
Tang Q, Song Y, Li X, Meng M, Zhang Q, Wang J, et al. Prognostic outcomes and risk factors for patients with renal cell carcinoma and venous tumor Thrombus after radical nephrectomy and Thrombectomy: the prognostic significance of venous tumor Thrombus level. Biomed Res Int. 2015;2015:163423.
Article
PubMed
PubMed Central
Google Scholar
Shi T, Huang Q, Liu K, Du S, Fan Y, Yang L, et al. Robot-assisted Cavectomy versus Thrombectomy for level II inferior vena cava Thrombus: decision-making scheme and multi-institutional analysis. Eur Urol. 2020;78(4):592–602.
Article
PubMed
Google Scholar
Wang B, Huang Q, Liu K, Fan Y, Peng C, Gu L, et al. Robot-assisted level III-IV inferior vena cava Thrombectomy: initial series with step-by-step procedures and 1-yr outcomes. Eur Urol. 2020;78(1):77–86.
Article
CAS
PubMed
Google Scholar
Paner GP, Stadler WM, Hansel DE, Montironi R, Lin DW, Amin MB. Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers. Eur Urol. 2018;73(4):560–9.
Article
PubMed
Google Scholar
Ljungberg B, Albiges L, Abu-Ghanem Y, Bensalah K, Dabestani S, Fernandez-Pello S, et al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75(5):799–810.
Article
PubMed
Google Scholar
Lawindy SM, Kurian T, Kim T, Mangar D, Armstrong PA, Alsina AE, et al. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. BJU Int. 2012;110(7):926–39.
Article
PubMed
Google Scholar
Liu Y, Song T, Huang Z, Zhang S, Li Y. The accuracy of multidetector computed tomography for preoperative staging of renal cell carcinoma. Int Braz J Urol. 2012;38(5):627–36.
Article
PubMed
Google Scholar
Guo HF, Song Y, Na YQ. Value of abdominal ultrasound scan, CT and MRI for diagnosing inferior vena cava tumour thrombus in renal cell carcinoma. Chin Med J. 2009;122(19):2299–302.
PubMed
Google Scholar
Ravina M, Hess S, Chauhan MS, Jacob MJ, Alavi A. Tumor thrombus: ancillary findings on FDG PET/CT in an oncologic population. Clin Nucl Med. 2014;39(9):767–71.
Article
PubMed
Google Scholar
Sharma P, Kumar R, Jeph S, Karunanithi S, Naswa N, Gupta A, et al. 18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus? Nucl Med Commun. 2011;32(9):782–8.
Article
PubMed
Google Scholar
Zhao Y, Wu C, Li W, Chen X, Li Z, Liao X, et al. 2-[(18)F]FDG PET/CT parameters associated with WHO/ISUP grade in clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2021;48(2):570–9.
Article
PubMed
Google Scholar
Wu C, Cui Y, Liu J, Ma L, Xiong Y, Gong Y, et al. Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging. 2021;48(12):4054–66.
Article
CAS
PubMed
Google Scholar
Wu C, Cui Y, Zhao Y, Chen X, Liao X, Di L, et al. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative (18)F-FDG PET/CT predicts poor prognosis of patients with clear cell renal cell carcinoma after nephrectomy. Eur J Radiol. 2020;131:109218.
Article
PubMed
Google Scholar
Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37(10):1490–504.
Article
PubMed
Google Scholar
Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of Tumours of the urinary system and male genital organs-part a: renal, penile, and testicular Tumours. Eur Urol. 2016;70(1):93–105.
Article
PubMed
Google Scholar
Hu S, Zhang J, Cheng C, Liu Q, Sun G, Zuo C. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Abdom Imaging. 2014;39(6):1221–7.
Article
CAS
PubMed
Google Scholar
Zhou J, Zhao L, Yang Z, Chen Y, Wu X, Xue W. Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas. BMC Urol. 2022;22(1):109.
Article
CAS
PubMed
PubMed Central
Google Scholar
Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, et al. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJU Int. 2012;110(1):76–83.
Article
PubMed
Google Scholar
Waldert M, Haitel A, Marberger M, Katzenbeisser D, Ozsoy M, Stadler E, et al. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. BJU Int. 2008;102(10):1381–4.
PubMed
Google Scholar
Del Rocío E-SG, Altamirano-Ley J, Ochoa-Carrillo FJ. Normal variants and frequent pitfalls with (18)FDG PET/CT study. Cir Cir. 2007;75(6):491–7.
Google Scholar
Zhu AH, Hou XY, Tian S, Zhang WF. Diagnostic value of (18)F-FDG PET/CT versus contrast-enhanced MRI for venous tumour thrombus and venous bland thrombus in renal cell carcinoma. Sci Rep. 2022;12(1):587.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang XM, Lu Y, Song YM, Dong J, Li RY, Wang GL, et al. Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus. Nat Commun. 2020;11(1):739.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gettman MT, Boelter CW, Cheville JC, Zincke H, Bryant SC, Blute ML. Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. J Urol. 2003;169(4):1282–6.
Article
PubMed
Google Scholar
Lyon TD, Gershman B, Shah PH, Thompson RH, Boorjian SA, Lohse CM, et al. Risk prediction models for cancer-specific survival following cytoreductive nephrectomy in the contemporary era. Urol Oncol. 2018;36(11):499 e1–7.
Article
PubMed
Google Scholar
Reese AC, Whitson JM, Meng MV. Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol. 2013;31(7):1305–9.
Article
PubMed
Google Scholar
Chen X, Li S, Xu Z, Wang K, Fu D, Liu Q, et al. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience. World J Surg Oncol. 2015;13:14.
Article
PubMed
PubMed Central
Google Scholar
Miyake H, Terakawa T, Furukawa J, Muramaki M, Fujisawa M. Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus. Eur J Surg Oncol. 2012;38(7):630–6.
Article
CAS
PubMed
Google Scholar
Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol. 2004;171(2 Pt 1):588–91.
Article
PubMed
Google Scholar
Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, et al. Prognostic factors for renal cell carcinoma with tumor thrombus extension. J Urol. 2007;178(4 Pt 1):1189–95 discussion 95.
Article
PubMed
Google Scholar